Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itacitinib in Myelofibrosis
NCT01633372Phase 2Completed
- Sponsor
- Incyte
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of itacitinib in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF), post-essential thrombocythemia myelofibrosis (PET-MF), sponsored by Incyte. Started Jul 2012; status: completed.
02
Drugs
itacitinib
03
Conditions
primary myelofibrosis (PMF)post-polycythemia vera myelofibrosis (PPV-MF)post-essential thrombocythemia myelofibrosis (PET-MF)
Beyond the preview
Go deeper on NCT01633372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633372.